Edition:
United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

47.22EUR
10:31am EDT
Change (% chg)

€0.25 (+0.53%)
Prev Close
€46.97
Open
€46.96
Day's High
€47.50
Day's Low
€46.85
Volume
673,690
Avg. Vol
1,720,292
52-wk High
€71.36
52-wk Low
€38.28

About

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes... (more)

Overall

Beta: 0.56
Market Cap(Mil.): €39,028.29
Shares Outstanding(Mil.): 554.54
Dividend: 0.62
Yield (%): 0.88

Financials

  FREG.DE Industry Sector
P/E (TTM): 22.53 27.89 32.55
EPS (TTM): 3.12 -- --
ROI: 9.33 6.65 13.82
ROE: 14.09 10.54 15.24

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

May 17 2019

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN, May 17 German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

May 17 2019

Fresenius talking to potential suitors about sale of blood transfusion business - sources

FRANKFURT Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.

May 15 2019

UPDATE 1-Fresenius talking to potential suitors about sale of blood transfusion business - sources

* Fresenius has hired Goldman Sachs for potential sale - sources

May 10 2019

Fresenius talking to potential suitors about sale of blood transfusion business - sources

FRANKFURT, May 10 Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.

May 10 2019

UPDATE 2-Fresenius makes solid start to year after turbulent 2018

* Confirms full-year guidance (Adds analysts, shares, details)

May 02 2019

Fresenius makes solid start to Q1 after troubled 2018

BERLIN, May 2 Fresenius reported a quarter of solid sales and earnings growth on Thursday helped by its generic infusion drugs and dialysis units and signs of stabilisation at its troubled German hospital business.

May 02 2019

Fresenius may not be ideal owner for some business activities: CEO

DUESSELDORF, Germany German healthcare group Fresenius is happy with its current portfolio but may consider selling some non-core business activities within its units, its chief executive told an association of business journalists on Wednesday evening.

Apr 11 2019

Fresenius may not be ideal owner for some business activities -CEO

DUESSELDORF, Germany, April 11 German healthcare group Fresenius is happy with its current portfolio but may consider selling some non-core business activities within its units, its chief executive told an association of business journalists on Wednesday evening.

Apr 11 2019

Fresenius flags faster earnings growth from 2020 after investment

BERLIN Fresenius expects earnings to grow faster than sales from 2020 after investments to improve its German hospitals and scale up its home dialysis business eat up profit this year, the German healthcare group said on Wednesday.

Feb 20 2019

Earnings vs. Estimates